MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Manuel
Crespo Hernández
Publicaciones en las que colabora con Manuel Crespo Hernández (9)
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2017
-
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2850-2856
2016
-
Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment
Antiviral Therapy, Vol. 21, Núm. 4, pp. 345-352
-
Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy
Journal of Infectious Diseases, Vol. 213, Núm. 6, pp. 1008-1012
2015
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6782-6790
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent hiv-infected patients in Spain
AIDS Patient Care and STDs, Vol. 28, Núm. 10, pp. 537-542
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849